AD patients have a greater susceptibility to deteriorate to severe stages of the disease when infected with SARS-CoV-2, resulting in increased mortality; the extant literature highlights the analysis of IL-6, a common biomarker in AD and SARS-CoV-2 infection [5,32]. Here, IL6 is linked to Alzheimer disease.